Bioline goes R&D
Monday, 19 November, 2007
Bioline has established a new research and development facility at the Australian Technology Park in Sydney.
The company, which manufactures and distributes reagents for molecular biology research throughout the world, is planning to develop new product lines at the lab for export to south east Asia, New Zealand and the US.
The Australian arm of Bioline was established in 2003 as a sales and distribution company. It now has six staff and annual sales of over $1 million.
The new facility was opened by NSW Minister for Science and Medical Research, Verity Firth.
Multiple myeloma treatment reprograms patients' own immune cells
An Australian and Victorian Government funding agreement has allowed eligible Australians with...
Could 'fusion proteins' reduce errors in a promising gene-editing tool?
Gene-editing tool CRISPR-Cas9 is used, among many things, to engineer new cancer immunotherapies....
Cancer research and clinical trials at the core of new centre
The Australian Cancer Research Foundation Centre for Dynamic Immuno-Oncology (CDIO) has been...
